In 2014, Greenville Health System spent more than double on employees with A1c greater than 7.5% compared to employees with A1c less than 7.5%. Visits with a primary care physician every three months may be inadequate to meet the needs of a patient with uncontrolled diabetes. The goal of the study was to improve care for a targeted population of employees of a large health care system with type 1 or 2 diabetes. The intervention combined diabetes education, telehealth, a wireless enabled meter, and algorithms for medication adjustments.

Methods: Fifty patients were given a wireless enabled meter that links to secure portal for the healthcare professional, the patient, and a support person. The primary objective was to achieve a 15 percent reduction in patients’ average baseline A1c. Secondary objectives included improving patient’s understanding of diabetes and self-management of diabetes, increasing adherence rates of diabetes monitoring and medication utilization, decreasing rates of hypoglycemic or hyperglycemic events, and reduce overall cost of healthcare. Patients were contacted by a diabetes educator every 2-4 weeks. A medication algorithm was used to titrate insulin and non-insulin medications and initiate additional treatments.

Results: Patients were followed for an average of 27.6 months. Baseline A1c average of 10.248 was reduced to an average of 8.392 (absolute reduction of 1.856 or 18% reduction from baseline). Compared to baseline, at 12 months patients reported improvement in their self-rated diabetes knowledge, self-monitoring behaviors, and self-management behaviors. Participants increased their outpatient visits with primary care providers and Endocrinology. Average cost for both endocrinology and PCP visits decrease from pre-enrollment to one year post enrollment.

In conclusion, by combining diabetes education, medication algorithms, and remote glucose monitoring, participants improved their knowledge of diabetes and self-care and experienced improved glycemic control.


J. Bruch: None. M.D. Stancil: None. J.M. Odom: None. B.A. Nelson: Speaker's Bureau; Self; Dexcom, Inc.. L.S. Reulbach: None. R. Russ-Sellers: None. A. Ghizzoni Burns: None. M.R. Lindholm: None. J. Dawson: None. N.A. Schwecke: None.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at